Phase III Study of Oral Compared With Intravenous Topotecan As Second-Line Therapy in Small-Cell Lung CancerJohn R. Eckardt, Graham Ross, Joachim von Pawel et al.|Journal of Clinical Oncology|2007Cited by 384